Choroiditis due to hypersensitivity secondary to inactive ocular tuberculosis. Case report
Lucía Echevarría-Lucas, M. Mar Góngora-Miñarro, Cristina Gómez-Cabrera, Margarita Jódar-Márquez, Juan J. Gómez-Fernández
Keywords :
Choroiditis due to hypersensitivity, Ocular tuberculosis, Immune reconstitution syndrome, Immunosuppressants
Citation Information :
Echevarría-Lucas L, Góngora-Miñarro MM, Gómez-Cabrera C, Jódar-Márquez M, Gómez-Fernández JJ. Choroiditis due to hypersensitivity secondary to inactive ocular tuberculosis. Case report. 2021; 95 (5E):208-213.
Purpose: To describe that the eye, after healing its active infectious stage, reacts similarly against several systemic infectious processes that affect its structures, such as tuberculosis, Ebola, or AIDS (together with its opportunist infections).
Case report: We report the case of a female patient that, after a successful treatment against ocular tuberculosis, developed a multifocal choroiditis due to delayed hypersensitivity, with more potential devastating effects than the active infection itself: inflammation of choroidal and retinal vessels, papillitis, and macular edema that, without treatment, may induce severe visual loss. The patient received short-term systemic corticosteroids and long-term maintenance with systemic immunosuppressants.
Conclusions: Ocular inflammatory reactions due to hypersensitivity are more destructive than the direct infection by different pathogens since there may be an inflammatory reaction secondary to the immune recognition of infectious antigenic particles in the ocular structures. Treatment is based on verifying that the active infection has been controlled and, subsequently, initiating systemic corticoids or corticosteroid-sparing immunosuppressive agents.
Adán Civera A. Avances en el diagnóstico y tratamiento de las infecciones intraoculares. Monografías de la Sociedad Española de Oftalmología; 2012. 168 p.
Tenorio-Guajardo G, Ramírez-Casanova E, González-Rodríguez E. Tuberculosis ocular. Serie de casos en el Hospital General de México. Rev Médica Hosp Gen México. 2014;77:17-23.
Shantha JG, Crozier I, Yeh S. An update on ocular complications of Ebola virus disease. Curr Opin Ophthalmol. 2017;28:600-6.
Shantha JG, Mattia JG, Goba A, Barnes KG, Ebrahim FK, Kraft CS, et al. Ebola Virus Persistence in Ocular Tissues and Fluids (EVICT) Study: reverse transcription-polymerase chain reaction and cataract surgery outcomes of Ebola survivors in Sierra Leone. EBioMedicine. 2018;30:217-24.
Ganesh SK, Abraham S, Sudharshan S. Paradoxical reactions in ocular tuberculosis. J Ophthalmic Inflamm Infect. 2019;9:19.
Robinson MR, Reed G, Csaky KG, Polis MA, Whitcup SM. Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy. Am J Ophthalmol. 2000;130:49-56.
Song M-K, Azen SP, Buley A, Torriani F, Cheng L, Chaidhawangul S, et al. Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis. Am J Ophthalmol. 2003;136:696-702.
Concha del Río LE, Garza León MA, González Rubio Medina E, Recillas Gispert C, Voorduin Ramos S, Ruiz Cruz M. Guías mexicanas para el manejo de uveítis no infecciosa en adultos. Centro Mexicano de Enfermedades Inflamatorias Oculares (CMEIO); 2019.
Red Nacional de Vigilancia Epidemiológica. Protocolo de vigilancia y alerta de tuberculosis. Sevilla: Junta de Andalucía; 2011. Disponible en: https://www.juntadeandalucia.es/export/drupaljda/salud_5af95879cd47b_pr_tuberculosis2011.pdf.
Echevarría Lucas L, Medialdea Hurtado ME, Villena Irigoyen O, De Ramón Garrido E. Granuloma tuberculoso macular asociado a membrana neovascular tratado con terapia anti-factor de crecimiento endotelial vascular. Archivos de la Sociedad Canaria de Oftalmología. 2018;29:77-83.
Cano Parra J, Díaz-Llopis M. Drug induced uveitis. Arch Soc Esp Oftalmol. 2005;80:137-49.
Julián K. ¿TB or not TB? El dilema de la uveítis asociada a tuberculosis. Oftalmol Clin Exp. 2013;6:35-44.
Ruiz-Cruz M, Alvarado de la Barrera C, Ablanedo Terrazas Y, Reyes Terán G. Proposed clinical definition for cytomegalovirus-immune recovery retinitis. Clin Infect Dis. 2014;59:298-303.
